Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Convalescent plasma therapy developed by the University of the West Indies (UWI) and University Hospital of the West Indies (UHWI) for the treatment of severe COVID-19. This biologic therapy involves the transfusion of plasma collected from recovered COVID-19 patients, which contains high titers of neutralizing antibodies against the SARS-CoV-2 virus. By providing passive immunity, the treatment aims to reduce viral replication, decrease biomarkers of inflammation, and lower the risk of death or the need for ventilatory support in patients with severe disease. A pilot clinical trial was initiated in Jamaica in 2020 to assess the efficacy and safety of this intervention.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on convalescent plasma (The University of The West Indies).